Several public health and tobacco control groups are upset that Philip Morris International would even consider purchasing a pharmaceutical maker that develops inhaled treatments for respiratory diseases, including the COVID-19 infection. NEW YORK CITY — Philip Morris International (PMI) announced recently that it would pursue purchasing a company specializing in the development of inhaled pharmaceutical treatments … Continue reading Groups Oppose Philip Morris International Purchasing Pharma Company Vectura